Vistagen Therapeutics (VTGN) Total Debt (2011 - 2026)
Vistagen Therapeutics (VTGN) posted Total Debt of $100000.0 for Q1 2026, down 87.25% sequentially from $784200.0 in Q2 2023.
Vistagen Therapeutics (VTGN) Total Debt (2011 - 2026) Analysis & Trends
Vistagen Therapeutics has reported Total Debt for 12 years, with the latest figure at $100000.0 in Q1 2026.
- Quarterly Total Debt changed N/A year-over-year to $100000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $100000.0 (changed N/A YoY) and the FY2026 annual result came in at $100000.0, changed N/A from the prior year.
- Total Debt slipped to $100000.0 in Q1 2026 per VTGN's latest filing, from $784200.0 in the prior quarter.
- Over five years, Total Debt peaked at $1.0 million in Q2 2022 and troughed at $100000.0 in Q1 2026.
- A 3-year average of $529400.0 and a median of $574550.0 in 2022 frame the typical range for Total Debt.
- The widest YoY moves for Total Debt: up 24.44% in 2023, down 24.44% in 2023.
- Over 3 years, Total Debt stood at $419100.0 in 2022, then soared by 87.12% to $784200.0 in 2023, then plunged by 87.25% to $100000.0 in 2026.
- According to Business Quant data, Total Debt over the past three periods registered $100000.0, $784200.0, and $105300.0 for Q1 2026, Q2 2023, and Q1 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.88 Bn | 132.03 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.62 Bn | 78.62 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 65.28 Bn | 60.10 Bn | 1.37 Bn | - |
| 4 | Moderna | 61.39 Bn | 56.25 Bn | 52.00 Mn | 591.00 Mn |
| 5 | BeOne Medicines | 42.11 Bn | 37.01 Bn | 1.53 Bn | 1.07 Bn |
| 6 | Alnylam Pharmaceuticals | 31.37 Bn | 28.06 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.76 Bn | 10.37 Bn | 668.28 Mn | 770.36 Mn |
| 8 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn | 546.77 Mn |
| 9 | Royalty Pharma | 27.24 Bn | 26.41 Bn | - | 9.34 Bn |
| 10 | Vistagen Therapeutics | 10.39 Mn | 10.39 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 100,000.00 |
| Jun 30, 2023 | 784,200.00 |
| Mar 31, 2023 | 105,300.00 |
| Dec 31, 2022 | 419,100.00 |
| Sep 30, 2022 | 730,000.00 |
| Jun 30, 2022 | 1.04 Mn |
| Dec 31, 2020 | 98,400.00 |
| Sep 30, 2020 | 439,900.00 |
| Jun 30, 2020 | 553,600.00 |
| Mar 31, 2020 | 113,000.00 |
| Dec 31, 2019 | 70,500.00 |
| Sep 30, 2019 | 159,300.00 |
| Jun 30, 2019 | 246,400.00 |
| Mar 31, 2019 | 114,600.00 |
| Dec 31, 2018 | 49,100.00 |
| Sep 30, 2018 | 115,600.00 |
| Jun 30, 2018 | 181,100.00 |
| Mar 31, 2018 | 107,800.00 |
| Dec 31, 2017 | 43,700.00 |
| Sep 30, 2017 | 105,200.00 |